Persons who take Elmiron to treat interstitial cystitis in the past three decades were exposed to a risk for eye damage and vision problems. Specifically, Elmiron has been found to cause eye problems in 24% of patients who take the drug for fifteen years or more, with significantly higher rates of eye damage for persons taking higher doses.
Elmiron is the only FDA-approved treatment for interstitial cystitis, and hundreds of thousands of patients--mostly women--have relied on the drug to relieve chronic pelvic and bladder pain. Elmiron fetches approximately $150 million each year in sales; critics says Johnson & Johnson officials had a responsibility to warn consumers of the risk of macular degeneration from Elmiron.
Persons who developed eye problems such as vision disturbances, loss of sight, or other types of eye damage from Elmiron are seeking clarification of the qualifications required to participate in an Elmiron eye lawsuit. Our law firm offers free, no-obligation, confidential consultations to anyone who feels they may have a claim, but we have outlined the basic qualifications in this section. In general, these are factors that are considered in each Elmiron eye lawsuit claim.
For persons and family members of persons who meet these qualifications, it is likely you will be eligible to file an Elmiron lawsuit for eye problems or vision loss. There are multiple reasons to file a claim. First, Elmiron lawyers believe individuals who have suffered from Elmiron eye problems may be eligible for compensation for the expense of medical treatment, pain, suffering, and loss associated with Elmiron eye problems. More meaningful than that to some is the opportunity to hold a large corporation accountable for patient safety and dishonest business practices. Critics say J&J and Janssen officials failed to warn consumers of the risk, putting hundreds of thousands of Americans at risk for Elmiron vision problems.